Press Releases

PRESS RELEASE For immediate release Devonian Health Group Announces the Journal of Drugs in Dermatology acceptance for publication of Thykamine™ positive phase 2 clinical trial results in Atopic Dermatitis.   QUEBEC, May 26, 2022 – Devonian Health Group Inc....

PRESS RELEASE For immediate release Devonian Announces Adoption of Restricted Share Unit Plan.   QUEBEC, March 17th, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD ; OTCQB : DVHGF), a clinical stage botanical pharmaceutical...

PRESS RELEASE For immediate release Devonian Health Group Announces trading on the OTCQB® Market under symbol DVHGF. QUEBEC, March 10, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical...

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS. QUEBEC, March 7, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical...

PRESS RELEASE For immediate release Devonian Health Group Announces voting results of the Annual General and Special Meeting and welcome new board members.   QUEBEC,  – March 1st , 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a...

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER AND GRANT OF STOCK OPTIONS.   QUEBEC, January 31st, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD),...

PRESS RELEASE For immediate release Devonian Announces Adoption of Shareholder Rights Plan and Modification to a Private Placement.   Not for distribution to United States newswire services or for dissemination in the United States   QUEBEC, January 27, 2022...

PRESS RELEASE For immediate release Devonian Health Group Announces Application for OTCQB listing.   QUEBEC, January 11, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation,...

PRESS RELEASE For immediate release Devonian Health Group Announces Publication of article on potential use of Thykamine™ in the treatment of Covid-19 in the International Journal of Noncommunicable Diseases.   QUEBEC, December 8, 2021 – Devonian Health Group...

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF SUBORDINATE VOTING SHARES IN SETTLEMENT OF A DEBT OWED TO A CONSULTANT AND THE GRANT OF STOCK OPTIONS.   Not for distribution to United States newswire services or for dissemination in the...